Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study

References

• Fox KAA, Steg PG, Eagle KA, Goodman SG, Anderson FA, Granger CB, et al. Decline rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 2007; 297: 1892–900
   PubMed Web of Science ®Google Scholar
• Antman, EM, Hand, M, Armstrong, PW, Bates, ER, Green, LA, Halasyamani, LK, , et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction). J Am Coll Cardiol. 2008;51:210–47.
   PubMedGoogle Scholar
• Van de Werf F, Bax JJ, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2008; 29: 2909–45
   PubMedGoogle Scholar
• Chen, ZM, Jiang, LX, Chen, YP, Xie, JX, Pan, HC, Peto, R, ; COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group), et al . Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607–21.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Cannon CP, Gibson GM, Lopez-Sendon JL, Montalescot G, Theroux P, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005; 352: 1179–89
   PubMed Web of Science ®Google Scholar
• Danchin N, Grenier O, Ferrières J, Cantet C, Cambou JP. Use of secondary preventive drugs in patients with acute coronay syndromes treated medically or with coronary angioplasty: results from the nationwide French Prevenir survey. Heart 2002; 88: 159–62
   PubMedGoogle Scholar
• Steg, PG, Iung, B, Feldman, LJ, Cokkinos, D, Deckers, J, Fox, KAA, , et al, For the Enact Investigators. Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes. Heart 2002;88:20–4.
   PubMedGoogle Scholar
• Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002; 23: 1190–201
   PubMed Web of Science ®Google Scholar
• Yan, AT, Yan, RT, Tan, M, Huynh, T, Soghrati, K, Brunner, LJ, , Canadian ACS Registries Investigators, et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J. 2007;154:1108–15.
   PubMedGoogle Scholar
• Granger, CB, Steg, PG, Peterson, E, López-Sendón, J, Van de Werf, F, Kline-Rogers, E, , GRACE Investigators, et al. Medication performance measures and mortality following acute coronary syndromes. Am J Med. 2005;118:858–66.
   PubMedGoogle Scholar
• Tricoci P, Peterson ED, Roe MT. Patterns of guideline adherence and care delivery for patients with unstable angina and non-ST-segment elevation myocardial infarction (from the CRUSADE Quality improvement initiative). Am J Cardiol. 2006; 98(Suppl)30Q–5Q
   Google Scholar
• Di Chiara, A, Fresco, C, Savonitto, S, Greco, C, Lucci, D, Gonzini, L, , et al, on behalf of the BLITZ-2 Investigators. Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: the BLITZ-2 study. Eur Heart J. 2006;27:393–405.
   PubMedGoogle Scholar
• Heras, M, Bueno, H, Bardají, A, Fernández-Ortiz, A, Martí, H, Marrugat, J, DESCARTES Investigators. Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry. Heart 2006;92:1571–6.
   PubMed Web of Science ®Google Scholar